Sharemaestro company-news research for Lucid Diagnostics Inc (LUCD), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Measured evidence
Company news sentiment
LUCD news sentiment
Lucid Diagnostics Inc
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone50Neutral is 50
Balanced news tone
40/100 evidence confidence
100% direct company focus
1 current stories across 1 publishers
Current company news
Price moving ahead of tone
Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.
Latest source headline Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview TradingView · 10 Aug 2026 22:19What supports the read
1 current stories are mapped specifically to LUCD.
What tempers the read
Only 1 publisher currently contribute to the measured read.
Price is moving more forcefully than the current news tone suggests.
50/100
Weighted toneBalanced news tone
40/100
Evidence confidencebuilding confidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth12
1.0 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness65
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Price is moving more forcefully than the current news tone suggests.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
News subjects
What is shaping the score
Earnings501 stories · 100%
Source mix
Where the evidence comes from
TradingView501 stories · 100%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#150Tone
TradingViewDirect company coverage
Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview
- Published
- 10 Aug 2026 22:19
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
LUCD news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
10
2026
TradingViewArchivedNeutral tone
Price to sales forward of Lucid Diagnostics Inc. – NASDAQ:LUCD
- Published
- 10 Aug 2026 06:11
- Catalyst
- Market update
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Aug
04
2026
BioSpaceArchivedNeutral tone
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
- Published
- 4 Aug 2026 11:34
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
25
2026
TradingKeyArchivedNeutral tone
Lucid Diagnostics Inc (LUCD) Earnings Forecast: Future EPS & Revenue Growth Estimates
- Published
- 25 Jul 2026 21:47
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
StocktwitsArchivedNeutral tone
LCID: Lucid Group Inc Latest Stock Price, Analysis, News and Trading Ideas
- Published
- 24 Jul 2026 04:10
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
23
2026
Ad-hoc-news.deArchivedNeutral tone
Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum
- Published
- 23 Jul 2026 11:05
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
22
2026
Ad-hoc-news.deArchivedNeutral tone
Abbott Laboratories stock steadies as medical devices and diagnostics underpin growth
- Published
- 22 Jul 2026 20:50
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
17
2026
Market sourceArchivedNeutral tone
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Published
- 17 Jul 2026 13:39
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
16
2026
Investing.comArchivedNeutral tone
Why is Lucid stock 10% today?
- Published
- 16 Jul 2026 16:25
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
14
2026
dars.gov.etArchivedNeutral tone
Lucid Diagnostics (LUCD) Nears One-Dollar Threshold After Modest Decline - Arms Index
- Published
- 14 Jul 2026 10:37
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
10
2026
dars.gov.etArchivedNeutral tone
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% Drop - Keltner Channel
- Published
- 10 Jul 2026 15:37
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
08
2026
GuruFocusArchivedNeutral tone
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
- Published
- 8 Jul 2026 19:00
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
04
2026
Seeking AlphaArchivedNeutral tone
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD)
- Published
- 4 Jul 2026 14:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
03
2026
www.marketscreener.comArchivedNeutral tone
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Small Cap Comp Value Benchmark
- Published
- 3 Jul 2026 08:01
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
TradingViewArchivedNeutral tone
Lucid Diagnostics Inc. Actuals & Estimates (BOATS:LUCD)
- Published
- 28 Jun 2026 00:07
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
TradingViewArchivedNeutral tone
Lucid Diagnostics Inc. Actuals & Estimates (NASDAQ:LUCD)
- Published
- 26 Jun 2026 11:15
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
Stock TitanArchivedNeutral tone
Lucid Diagnostics (LUCD) boosts authorized shares to 400M and re-elects directors
- Published
- 25 Jun 2026 02:35
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
24
2026
TradingKeyArchivedNeutral tone
Lucid Diagnostics Inc (LUCD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
- Published
- 24 Jun 2026 15:53
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.